Cutaneous reactions to antibacterial agents.

Area of Science:

• Dermatology
• Pharmacology
• Immunology

Background:

• Antibacterial agents can induce a spectrum of adverse reactions, ranging from mild erythema to severe, life-threatening conditions like toxic epidermal necrolysis.
• Drug eruptions encompass various dermatological manifestations, necessitating accurate diagnosis for appropriate patient management.
• Hypersensitivity reactions to drugs can manifest with systemic involvement, including endocrine and autoimmune disorders.

Purpose of the Study:

• To review the diverse untoward reactions associated with antibacterial agents.
• To highlight the diagnostic utility of in vivo and in vitro tests for drug eruptions.
• To discuss associated syndromes such as drug hypersensitivity syndrome and drug-induced lupus erythematosus.

Main Methods:

• Review of literature on antibacterial agent adverse reactions.
• Discussion of diagnostic approaches for drug-induced skin reactions.
• Analysis of clinical presentations and differential diagnoses of severe cutaneous adverse reactions.

Main Results:

• Adverse reactions to antibacterials vary widely, from mild skin rashes to severe conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis.
• In vivo and in vitro tests are valuable tools for diagnosing the specific agent responsible for drug eruptions.
• Drug hypersensitivity syndrome can present with thyroid abnormalities, and drug-induced lupus erythematosus may manifest with polyarthritis, fever, and malaise.

Conclusions:

• Accurate diagnosis of drug eruptions is crucial for managing adverse reactions to antibacterial agents.
• Diagnostic testing aids in identifying causative agents and associated systemic syndromes.
• Recognition of diverse clinical presentations, including Stevens-Johnson syndrome and toxic epidermal necrolysis, is essential for patient outcomes.